Last reviewed · How we verify
NCT04758598
The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study
NA trial testing Direct Selective Laser Trabeculoplasty (DSLT) in Open Angle Glaucoma in 20 participants. Completed in 6 May 2022.
15 April 2022
Quick facts
| Lead sponsor | BelkinVision |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 1 March 2021 |
| Primary completion | 15 April 2022 |
| Estimated completion | 6 May 2022 |
| Sites | 1 location across Georgia |
Drugs / interventions tested
- Direct Selective Laser Trabeculoplasty (DSLT)
- Selective Laser Trabeculoplasty (SLT)
Conditions studied
- Open Angle Glaucoma — all drugs for Open Angle Glaucoma →
Sponsor
BelkinVision
Who can join
40 and older, any sex, with Open Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to compare the long-term (6 months) effects of Direct Selective Laser Trabeculoplasty (DSLT) treatment and SLT (Selective Laser Trabeculoplasty) treatment on corneal endothelial cell counts and corneal thickness.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04758598
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Direct Selective Laser Trabeculoplasty (DSLT)
Trials testing the same drug.
- NCT07300852 — DSLT in Normal Tension Glaucoma (NTG) Asian Eyes · NA · not yet recruiting
Other recruiting trials for Open Angle Glaucoma
Currently open trials in the same condition.
- NCT07228221 — Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma · Phase 4 · recruiting
- NCT06883123 — Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost · Phase 4 · recruiting
- NCT06666855 — A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China · Phase 3 · active not recruiting
- NCT06246136 — Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery · NA · recruiting
- NCT06061718 — Travoprost Intraocular Implant in Conjunction With Cataract Surgery · Phase 3 · active not recruiting
Other BelkinVision trials
Trials by the same sponsor.
- NCT05043831 — Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial · NA · withdrawn
- NCT05271734 — Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Pro · NA · completed
- NCT03750201 — A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04758598 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BelkinVision
- Last refreshed: 17 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04758598.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing